12th Annual CMHC

October 4-7

Boston, MA

The Cardiometabolic Event of the Year™

12th Annual CMHC Accreditation


Activity Title:

12th Annual Cardiometabolic Health Congress

Activity Date

October 4-7, 2017

Target Audience

The CMHC is designed for advanced level clinicians responsible for the prevention, diagnosis, and management of cardiometabolic risk including cardiologists, endocrinologists, diabetologists, lipidologists, pharmacists, primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), and other allied health professionals.

Statement of Need/Program Overview

The ever-increasing presence of cardiometabolic risk continues to be a major challenge for health care providers in the United States. Current estimates suggest approximately 23% - 38% of all U.S. adults have metabolic syndrome, a constellation of cardiometabolic risk factors, including excessive abdominal fat, insulin resistance, inflammation, dyslipidemia, and hypertension. Patients with multiple cardiometabolic risk factors have twice the likelihood of developing and dying from cardiovascular disease and more than seven times the risk of developing diabetes compared to those with no cardiometabolic risk factors. Cardiovascular disease already affects approximately 83.6 million U.S. adults (> 1 in 3) and is the leading cause of U.S. deaths; however, this CVD burden can be expected to increase.

This sampling of sobering statistics points to a rapidly growing epidemic of cardiovascular and metabolic disease and calls to the forefront the need for medical education focused on all aspects of cardiometabolic risk. The CMHC presents an especially valuable venue for this educational outreach with sessions fostering a collaborative, multidisciplinary approach to care.

The 2017 Cardiometabolic Health Congress will translate the latest cutting edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders. The goal is to provide the medical community with evidence based interventions to improve health outcomes and quality of life for the growing numbers of patients at increased cardiometabolic risk.

Educational Objectives

After completing this activity, the participant should be better able to:

  • DEFINE the interrelationships among cardiometabolic risk factors, their impact on cardiovascular health, and their common comorbidities
  • DESCRIBE evidence-based guideline recommendations based on recent clinical trials for prevention, screening, and treatment of cardiometabolic risk factors and their comorbidities
  • IDENTIFY treatment regimens for cardiometabolic diseases based on efficacy and safety of current, new, and emerging pharmacotherapies, benefits of lifestyle modifications, and patient profiles and preferences to optimize patient outcomes
  • IMPLEMENT communication strategies and patient education on new and emerging treatments, administration techniques, and technologies into clinical practice in order to promote adherence to treatment regimens


Please click here to view all faculty listings.

Program Agenda

Please click here to view the full agenda.

SCOPE Certification

The World Obesity/Clinical Care committee decided that the further learning value, quality and structure of the 12th Annual Cardiometabolic Health Congress comply with Specialist Certification of Obesity Professional Education (SCOPE) principles. This event has been accredited with 4 SCOPE Points which count towards SCOPE Certification.

SCOPE Certification is conferred by the World Obesity Federation and is the internationally-recognized standard of excellence in obesity management. SCOPE Certification is awarded to health professionals with obesity management experience who have earned 12 SCOPE points.

For questions regarding SCOPE points, please contact info@cardiometabolichealth.org.

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This educational activity for 28 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity. 

Pharmacist Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Global Education Group designates this continuing education activity for 28 contact hour(s) (2.8 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity. Universal Activity Numbers (UAN) are listed below.

Session Title


Pre-Conference “Business of Medicine” Day

The Patient-Centered Medical Home: A Foundation for Patient Satisfaction


Efficient and Cost Effective Management of the Authorization Process Supported by an educational grant from Sanofi US and Regeneron Pharmaceuticals


Expert Discussion: The Psychology Behind Patient Adherence


How to Grow Your Revenue By Enhancing Your Presence: In Person, On Camera & Online


Session I. Dyslipidemia, Atherosclerosis and Cardiovascular Risk Reduction

CME Breakfast Symposium: Closing the Gap Created by Clinical Inertia: New Strategies for T2DM Treatment


FDA Update and Late Breaking Clinical Trials


Attacking Atherothrombosis: Which Approach to Take?


MAIN KEYNOTE: Gut Microbes as a Participant and Therapeutic Target in Cardiometabolic Diseases


CME Lunch Symposium: Navigating Updated Guidelines and New Therapies for the Diagnosis and Treatment of Heart Failure


Lp(a) and Promising NEW Targets for Intervention


Treatment for Statin Intolerant Patients with Hypercholesterolemia – Today and Tomorrow


Topic: Triglycerides and HDL-C: Where Are We Now?


Multidisciplinary Case Consults: Challenging Lipid Cases


CME Dinner Symposium: Advances in Insulin Therapy: Addressing Provider and Patient Safety Concerns


Session II. Lifestyle Management of Cardiovascular Disease

CME Breakfast Symposium: Interventional Cardiology Delivered With a Fork


Ensuring Access to Evidence-Based Therapies in High Risk Special Populations: Statin Intolerance, Racial/Ethnic Minorities and Familial Hypercholesterolemia


Topic: Novel Mechanisms for the Link Between Obesity and Type 2 Diabetes


Cardiometabolic Disorders: Diet Quality, Quantity and Beyond


Sleep Science: Effect of the Circadian Rhythm on Obesity and CVD


Multidisciplinary Case Consults: Lifestyle and Obesity Management in the Cardiometabolic Patient


CME Lunch Symposium: CV Protection: Is It Achievable in Patients with T2DM?


Session III. Diabetes Management

New Insights Into Insulin Resistance and How the Body Responds to It


Reaching Glycemic Goals for Patients with T2DM: Insulin and Non-Insulin Therapies


Managing Microvascular Complications of Diabetes for Improved Patient Outcomes


Multidisciplinary Case Consults: Challenging T2DM Patient Cases


Session IV. Hypertension, Cardio-Renal, Heart Failure

CME Breakfast Symposium: Hyperkalemia Management and Monitoring in High-Risk Patients: Improving Heart Failure Management and Outcomes


Topic: Metabolomics and Kidney Disease


2017 Guideline Updates: Blood Pressure and Resistant Hypertension


Integrative Topics in Blood Pressure and Hypertension Management


Multidisciplinary Case Consults: Challenging Patient Cases in Hypertension, Cardio-Renal, and Heart Failure


Kidney Disease in the Elderly


Dietician Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). CDR Credentialed Practitioners will receive 28 Continuing Professional Education units (CPEUs) for completion of this activities / materials.
CPE Provider #GE012

Global Contact Information

For information about the accreditation of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

Instructions to Receive Credit

In order to receive credit for this activity, the participant must complete the CMHC Program Evaluation. A link to the online evaluation will be emailed to all participants by approximately Monday, October 9, 2017. Online evaluations must be completed by October 31, 2017. CME/CE Certificates will be available for print immediately upon completion of the online evaluation form.

Pharmacists Only: In order to receive credit, the ACPE requires that you provide your NABP ePID (6 digits) along with month and date of birth (MMDD) in the online evaluation. After completion of the evaluation via steps outlined above, record of your participation will be uploaded to the CPE Monitor under your NABP e-profile within 60 days. You may print an individual statement of credit for this activity from your NABP e-profile. CMHC strongly encourages you to check your e-profile to ensure your credit is appropriately claimed before December 4, 2017.

Fee Information & Refund/Cancellation Policy

There is registration fee for this educational activity, registration information can be found here.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Educational Grant Support

The 2017 Cardiometabolic Health Congress general sessions are supported in part by an independent and unrestricted educational grant from Pfizer.

For educational symposia support please visit this page.

Joint Providership Statement

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.